##fileformat=VCFv4.1
##fileDate=20160811
##source=strelka
##source_version=2.0.17.strelka1
##startTime=Thu Aug 11 11:01:30 2016
##FORMAT=<ID=AU,Number=2,Type=Integer,Description="Number of 'A' alleles used in tiers 1,2">
##FORMAT=<ID=CU,Number=2,Type=Integer,Description="Number of 'C' alleles used in tiers 1,2">
##FORMAT=<ID=GU,Number=2,Type=Integer,Description="Number of 'G' alleles used in tiers 1,2">
##FORMAT=<ID=TU,Number=2,Type=Integer,Description="Number of 'T' alleles used in tiers 1,2">
##FORMAT=<ID=TAR,Number=2,Type=Integer,Description="Reads strongly supporting alternate allele for tiers 1,2">
##FORMAT=<ID=TIR,Number=2,Type=Integer,Description="Reads strongly supporting indel allele for tiers 1,2">
##FORMAT=<ID=TOR,Number=2,Type=Integer,Description="Other reads (weak support or insufficient indel breakpoint overlap) for tiers 1,2">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Allele|Consequence|IMPACT|SYMBOL|Gene|gnomAD_AF|Feature|BIOTYPE|EXON|HGVSc|HGVSp|cDNA_position|CDS_position|Protein_position|Amino_acids|Codons">
##INFO=<ID=gnomADg_AF,Number=A,Type=Float,Description="Alternate allele frequency in samples (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
##INFO=<ID=gnomADg_AC,Number=A,Type=Float,Description="Alternate allele count (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
##INFO=<ID=gnomADg_Hom,Number=A,Type=Integer,Description="Count of homozygous individuals in samples (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
##INFO=<ID=gnomADg_Hemi,Number=A,Type=Integer,Description="Alternate allele count for male samples (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
##INFO=<ID=gnomADg_Het,Number=A,Type=Integer,Description="Count of heterozygous alleles in all samples. (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
##INFO=<ID=gnomADg_Wt,Number=A,Type=Integer,Description="Count of wildtype alleles in all samples. (from file gnomAD_genome_v3.1.2_GRCh38.vcf.gz)">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	normal	tumor
chr17	26898195	.	G	GC	0.0	PASS	IC=2;IHP=5;NT=ref;QSI=68;QSI_NT=68;RC=1;RU=C;SGT=ref->het;TQSI=1;TQSI_NT=1;SOMATIC;CSQ=GC|frameshift_variant|HIGH|rs1234|PIGS|0.0001|NM_033198.3|protein_coding|2/12|c.58dupG|p.Ala20fs|431/2873|58/1668|20/555||;gnomADg_AF=0.0001	DP:DP2:DP50:FDP50:SUBDP50:TAR:TIR:TOR	52:52:59.58:0.02:0.00:51,51:0,0:0,0	52:52:56.41:0.07:0.00:27,27:17,17:7,7
chr17	38645127	.	G	A	0.0	PASS	NT=ref;QSS=86;QSS_NT=86;SGT=GG->AG;TQSS=1;TQSS_NT=1;SOMATIC;CSQ=A|splice_region_variant&intron_variant|LOW|TNS4|TNS4|0.0234|NM_032865.5|protein_coding|2/12|c.440-6C>T||||||;gnomADg_AF=0.0234	AU:CU:DP:FDP:GU:SDP:SUBDP:TU	0,0:0,0:90:1:89,91:0:0:0,0	20,21:0,0:70:2:48,50:0:0:0,0
chr17	37881000	.	G	T	0	LowEVS	DP=3011;MQ=59.98;MQ0=0;NT=ref;QSS=3070;QSS_NT=3070;ReadPosRankSum=0.61;SGT=GG->GT;SNVSB=0.00;SomaticEVS=17.62;TQSS=1;TQSS_NT=1;SOMATIC;CSQ=T|missense_variant|MODERATE|ERBB2|3430|ENST00000269571|Transcript|20/27||ENST00000269571.5:c.2329G>T|ENSP00000269571.4:p.Val777Leu|Gene3D:3.30.200.20&Pfam_domain:PF07714&PIRSF_domain:PIRSF000619&PROSITE_profiles:PS50011&hmmpanther:PTHR24416&hmmpanther:PTHR24416:SF137&SMART_domains:SM00219&Superfamily_domains:SSF56112&Transmembrane_helices:TMhelix|deleterious(0.05)|benign(0.036)|rs121913471&COSV54062385&COSV54062767&COSV54069186||||||||protein_coding|0.284|0.98627|0.96238|||||||9.85099983215332|164870_[GENE%3DERBB2_PHENOS%3DGlioblastoma&somatic&137800/Adenocarcinoma_of_lung&somatic&211980/Gastric_cancer&somatic&613659/Ovarian_cancer&somatic],T|downstream_gene_variant|MODIFIER|MIEN1|28230|ENST00000394231|Transcript||||||||rs121913471&COSV54062385&COSV54062767&COSV54069186||||||||protein_coding||0.98627|0.96238|||||||9.85099983215332|164870_[GENE%3DERBB2_PHENOS%3DGlioblastoma&somatic&137800/Adenocarcinoma_of_lung&somatic&211980/Gastric_cancer&somatic&613659/Ovarian_cancer&somatic]	DP:FDP:SDP:SUBDP:AU:CU:GU:TU	806:8:0:0:0,0:0,1:797,811:1,2	2166:39:0:0:1,2:1,1:392,405:1733,1783